AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

DIA 2019 Global Annual Meeting

June 23-27, 2019  |  San Diego, CA

 

The DIA 2019 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s performance in the development ecosystem.

Download the DIA 2019 Global Annual Meeting Schedule At-A-Glance for session times and to help plan out your days. Download >>

 

Join Avoca for the Following Sessions:

Monday, June 24  |  11:00am – 12:00pm

Quality Management Post-Quality Management System Implementation In The Wake of ICH E6 (R2)

Component Type: Forum

Level: Intermediate

Chair: Jay Turpen, Senior Consultant, The Avoca Group

Learning Objectives: Discuss the differing characteristics of a QMS based on the size of the organization; Compare how these characteristics changed in preparation for ICH E6 R2 implementation; Determine whether risk-based approaches vary based on organizational size and what organizations of different sizes can learn from each other.

Panelists:
RJ Doornbos, Head of Global Quality Systems, Global Quality, BMS
Michael Husovich, Director, Global R&D Quality, Amgen Inc.
Lenna Kimball, Vice President of Clinical Operations, Lyell Biotech

 

Monday, June 24  |  3:30pm – 4:30pm

Compliance: The Importance of Periodic Screenings to Ensure Good Inspection Health

Component Type: Forum

Level: Intermediate

Learning Objectives: Demonstrate how periodic screenings are an important part of inspection readiness; Discuss where hidden challenges lurk and how mock inspections can bring these items to light; Identify appropriate remediation plans that are organizationally focused and not study specific.

Speakers:
Grace Crawford, Vice President, Clinical Quality and Compliance, MedImmune
Barbara Maley, Senior Consultant, The Avoca Group

 

Tuesday, June 25  |  8:00am – 9:15am

DISC and RISK: How DISC Profile in Clinical Trial Teams Impact Implementation of Risk-Based Approaches

Component Type: Workshop

Level: Basic

Chair: Dawn Auerbach, Executive Director, Client Development, The Avoca Group

Learning Objectives: Identify your DISC personality type; Identify strategies for analyzing the situation from an alternative viewpoint/DISC type to facilitate change management and adoption; Discuss how personality type variations in clinical trial execution impact risk-based approach implementation and may be leveraged for success.

Speakers:
Jay Turpen, Senior Consultant, The Avoca Group
Bill Bennett, CEO, Empowering Leadership

To gain even more value from attending the DISC and RISK workshop—for a limited time—we’re giving away FREE DISC Personality Assessments. Your completed assessment—done prior to attending the workshop—will be emailed to you immediately upon completion. A copy will also be available at the workshop so that you can apply your own assessment results to the materials taught in the session.

To receive your free DISC assessment, email dawn.auerbach@theavocagroup.com.

 

Wednesday, June 26  |  4:15pm – 5:30pm

A New Path Forward for Using Decentralized Clinical Trials

Component Type: Forum

Level: Intermediate

Chair: Penny Randall, Vice President and Head, CNS Center of Excellence, IQVIA

Learning Objectives: Describe proven methods for executing decentralized clinical trials through telemedicine and mobile healthcare providers; Discuss actionable recommendations for navigating state medical licensing laws and issues with drug supply chain of custody; Identify the broad continuum of hybrid protocol designs possibilities for implementing decentralized clinical trials.

Panelists:
Gail Adinamis, CEO, GlobalCare Clinical Trials, LLC
Michael O’Brien, Chief Strategy Officer, Diligent Pharma
Laura Podolsky, General Counsel, Science 37, Inc.

 

To schedule a meeting with an Avoca representative at DIA 2019, contact us.